Back to Journals » Infection and Drug Resistance
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3509)
- Volume 17, 2024 (115)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Antimicrobial Stewardship and Infection Control: A Global Perspective (1)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
Mechanisms of Antibiotic Resistance and Developments in Therapeutic Strategies to Combat Klebsiella pneumoniae Infection
Li Y, Kumar S, Zhang L
Infection and Drug Resistance 2024, 17:1107-1119
Published Date: 19 March 2024
COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern – Mixed-Method Systematic Review
Andreescu M, Moldovan C, Lespezeanu DA, Mocanu AI, Schipor MA, Mocanu H
Infection and Drug Resistance 2024, 17:387-402
Published Date: 31 January 2024
Similarities and Differences Between Diabetes-Related and Trauma-Related Calcaneal Osteomyelitis: Comparisons Based on 681 Reported Cases
Liu GQ, Chen P, Huang MZ, Song MR, Song CS, Zhu RJ, Xiong J, Jiang N, Yu B
Infection and Drug Resistance 2023, 16:7547-7557
Published Date: 8 December 2023
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
Diethelm-Varela B, Soto JA, Riedel CA, Bueno SM, Kalergis AM
Infection and Drug Resistance 2023, 16:2061-2074
Published Date: 8 April 2023
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review
Chuang YC, Lin KP, Wang LA, Yeh TK, Liu PY
Infection and Drug Resistance 2023, 16:661-675
Published Date: 30 January 2023
Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies
Dvorkin J, De Luca J, Alvarez-Paggi D, Caballero MT
Infection and Drug Resistance 2023, 16:595-605
Published Date: 27 January 2023
Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China
Qiu W, Zheng C, Huang S, Zhang Y, Chen Z
Infection and Drug Resistance 2022, 15:6829-6837
Published Date: 28 November 2022
Age-Dependent Clinical Characteristics of Acute Lower Respiratory Infections in Young Hospitalized Children with Respiratory Syncytial Virus Infection
Li L, Wang H, Liu A, Chen J, Yang Y, Wang W
Infection and Drug Resistance 2022, 15:5971-5979
Published Date: 18 October 2022
Performance Evaluation of TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR Multiplex Assay for the Detection of Respiratory Viruses
Neopane P, Nypaver J, Shrestha R, Beqaj S
Infection and Drug Resistance 2022, 15:5411-5423
Published Date: 12 September 2022